(Q38082552)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419165%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

title

Challenges in drug target discovery in bipolar disorder (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419165%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419165%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Paul C Guest

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419165%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

Murtada Alsaif

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419165%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Hassan Rahmoune

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419165%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Sabine Bahn

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419165%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

language of work or name

English

0 references

publication date

18 February 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419165%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Therapeutic Targets

24 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419165%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419165%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419165%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

565-577

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23419165%20AND%20SRC:MED&resulttype=core&format=json

Unrecognised bipolar disorder in primary care patients with depression

24 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Quality of life in bipolar disorder: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Neurocognitive impairment in euthymic patients with bipolar affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Diagnostic conversion from depression to bipolar disorders: results of a long-term prospective study of hospital admissions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Meta-analysis of genetic association studies on bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Selective DNA methylation of BDNF promoter in bipolar disorder: differences among patients with BDI and BDII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Brain-derived neurotrophic factor val66met genotype and early life stress effects upon bipolar course

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Histone deacetylases and mood disorders: epigenetic programming in gene-environment interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Going viral: next-generation sequencing applied to phage populations in the human gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Control of messenger RNA stability in higher eukaryotes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

From proteins to proteomes: large scale protein identification by two-dimensional electrophoresis and amino acid analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Perspectives of targeted mass spectrometry for protein biomarker verification

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

High-throughput protein arrays: prospects for molecular diagnostics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Flow cytometry for drug discovery, receptor pharmacology and high-throughput screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Multiplex bead array assays: performance evaluation and comparison of sensitivity to ELISA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Tissue profiling by mass spectrometry: a review of methodology and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Can we discover novel pathways using metabolomic analysis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Metabolic fingerprints of serum, brain, and liver are distinct for mice with cerebral and noncerebral malaria: a ¹H NMR spectroscopy-based metabonomic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Solvent-dependent metabolite distribution, clustering, and protein extraction for serum profiling with mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

HMDB: the Human Metabolome Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Multi-platform characterization of the human cerebrospinal fluid metabolome: a comprehensive and quantitative update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Qualitative methods in early-phase drug trials: broadening the scope of data and methods from an RCT of N-acetylcysteine in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Brain-derived neurotrophic factor and neuroplasticity in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Investigation of serum high-sensitive C-reactive protein levels across all mood states in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

RNA-Seq of human neurons derived from iPS cells reveals candidate long non-coding RNAs involved in neurogenesis and neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Animal models relevant to schizophrenia and autism: validity and limitations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Pollen-specific immunoglobulin E positivity is associated with worsening of depression scores in bipolar disorder patients during high pollen season

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Accounting for population stratification in practice: a comparison of the main strategies dedicated to genome-wide association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Population stratification and spurious allelic association

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Gender differences in prevalence, risk, and clinical correlates of alcoholism comorbidity in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Gender differences in depression: findings from the STAR*D study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Peripheral profiling analysis for bipolar disorder reveals markers associated with reduced cell survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Gender differences in affective, schizoaffective, and schizophrenic disorders. A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Relationship of general medical burden, duration of illness and age in patients with bipolar I disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Glycogen synthase kinase-3 beta is highly activated in nuclei and mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Mitochondrially mediated plasticity in the pathophysiology and treatment of bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Glycogen synthase kinase-3beta phosphorylates Bax and promotes its mitochondrial localization during neuronal apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Mood stabilizers target cellular plasticity and resilience cascades: implications for the development of novel therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Modulation of phosphoinositide-protein kinase C signal transduction by omega-3 fatty acids: implications for the pathophysiology and treatment of recurrent neuropsychiatric illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Alterations in brain phosphorous metabolism in bipolar disorder detected by in vivo 31P and 7Li magnetic resonance spectroscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Measurement of brain phosphoinositide metabolism in bipolar patients using in vivo 31P-MRS

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Modulation of protein kinase C isozymes and substrates by lithium: the role of myo-inositol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

A review of the possible relevance of inositol and the phosphatidylinositol second messenger system (PI-cycle) to psychiatric disorders--focus on magnetic resonance spectroscopy (MRS) studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Decreased brain-derived neurotrophic factor in medicated and drug-free bipolar patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Brain-derived neurotrophic factor serum levels before and after treatment for acute mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Neurotrophic signaling cascades in the pathophysiology and treatment of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Therapeutic use of omega-3 fatty acids in bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Mapping global histone acetylation patterns to gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Epigenetic regulation in psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Valproic acid and chromatin remodeling in schizophrenia and bipolar disorder: preliminary results from a clinical population

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

The language of covalent histone modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

The contributions of oxytocin and vasopressin pathway genes to human behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Alterations in plasma prolyl endopeptidase activity in depression, mania, and schizophrenia: effects of antidepressants, mood stabilizers, and antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

A common mechanism of action for three mood-stabilizing drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Modulation of inositol 1,4,5-triphosphate concentration by prolyl endopeptidase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

How can the mood stabilizer VPA limit both mania and depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Higher serum prolyl endopeptidase activity in patients with post-traumatic stress disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Starvation-induced hyperactivity in the rat: the role of endocrine and neurotransmitter changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

The relationship between free and total calcium concentrations in the matrix of liver and brain mitochondria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Increased expression of endoplasmic reticulum stress proteins following chronic valproate treatment of rat C6 glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Chronic valproate treatment increases expression of endoplasmic reticulum stress proteins in the rat cerebral cortex and hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Mood stabilizing drug lithium increases expression of endoplasmic reticulum stress proteins in primary cultured rat cerebral cortical cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Endoplasmic reticulum chaperones GRP78 and calreticulin prevent oxidative stress, Ca2+ disturbances, and cell death in renal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

L-type calcium channels and psychiatric disorders: A brief review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Regulation of ER stress proteins by valproate: therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Reduction of brain phosphocreatine in bipolar II disorder detected by phosphorus-31 magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Brain phosphorous metabolism in depressive disorders detected by phosphorus-31 magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Reduced intracellular pH in the basal ganglia and whole brain measured by 31P-MRS in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Brain metabolic alterations in medication-free patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Genetic markers within glutamate receptors associated with antidepressant treatment-emergent suicidal ideation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Novel endocrine disrupter effects of classic and atypical antipsychotic agents and divalproex: induction of adrenal hyperandrogenism, reversible with metformin or rosiglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

PPARgamma agonists as therapeutics for the treatment of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Insulin dysfunction and allostatic load in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

A randomized, double-blind, controlled trial evaluating the effect of intranasal insulin on neurocognitive function in euthymic patients with bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Competact, a fixed combination of pioglitazone and metformin, improves metabolic markers in type 2 diabetes patients with insufficient glycemic control by metformin alone--results from a post-marketing surveillance trial under daily routine conditio

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Cerebral glucose utilization and platelet mitochondrial complex I activity in schizophrenia: A FDG-PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Transcriptomic analysis of the stress response to weaning at housing in bovine leukocytes using RNA-seq technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Mass cytometry: technique for real time single cell multitarget immunoassay based on inductively coupled plasma time-of-flight mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Multiplexed mass cytometry profiling of cellular states perturbed by small-molecule regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

From single cells to deep phenotypes in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Modelling schizophrenia using human induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Altered levels of circulating insulin and other neuroendocrine hormones associated with the onset of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Algorithm development for diagnostic biomarker assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Systems biology, bioinformatics, and biomarkers in neuropsychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Hybrid modeling in computational neuropsychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Affective disorders as complex dynamic diseases--a perspective from systems biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169

Analytical Method Development and Validation for the Academic Researcher

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.2013.771169